Home › Funds › YCG, LLC › JNJ

YCG, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

YCG, LLC reported holding 2,858 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$757K, representing 0.07% of its reported portfolio and ranking #37 among its reported holdings. YCG, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.86K sh
Reported value held$756.63K
Portfolio Weight0.07%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How YCG, LLC's JNJ position evolved

YCG, LLC first disclosed a stake in JNJ in Q3 2023 at 7,965 shares (US$1.2M). The position peaked in Q4 2023 at 7,965 shares, worth US$1.2M. Across 13 filings, YCG, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 2,858 shares valued at US$757K. Notable position changes include a 55% trim in Q1 2024 (shares fell 8% over the following quarter), a 34% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.96K $1.24M New
Q4 2023 7.96K $1.25M Hold
Q1 2024 3.56K $542.91K Reduce
Q2 2024 3.50K $511.56K Reduce
Q3 2024 3.50K $567.21K Hold
Q4 2024 3.50K $506.17K Hold
Q1 2025 3.50K $580.44K Hold
Q2 2025 3.50K $534.62K Hold
Q3 2025 3.50K $648.97K Hold
Q4 2025 4.34K $898.16K Add
Q1 2026 2.86K $698.61K Reduce
Q2 2026 2.86K $725.85K Hold
Q3 2026 2.86K $756.63K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has YCG, LLC held JNJ?

YCG, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is YCG, LLC's current position in JNJ?

As of Q3 2026, YCG, LLC holds 2.86K shares of JNJ (JOHNSON & JOHNSON), valued at $756.63K, representing 0.07% of its reported portfolio and ranking #37.

Has YCG, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), YCG, LLC held unchanged its position in JNJ. The position peaked in Q4 2023 at 7.96K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.